ES2158809B1 - NEW SULFONATED DERIVATIVES AS INHIBITORS OF CYCLLOXYGENASA II. - Google Patents

NEW SULFONATED DERIVATIVES AS INHIBITORS OF CYCLLOXYGENASA II.

Info

Publication number
ES2158809B1
ES2158809B1 ES9902286A ES9902286A ES2158809B1 ES 2158809 B1 ES2158809 B1 ES 2158809B1 ES 9902286 A ES9902286 A ES 9902286A ES 9902286 A ES9902286 A ES 9902286A ES 2158809 B1 ES2158809 B1 ES 2158809B1
Authority
ES
Spain
Prior art keywords
sup
sub
inhibitors
cyclooxygenase
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9902286A
Other languages
Spanish (es)
Other versions
ES2158809A1 (en
Inventor
Casellas David Mauleon
Perez M Luisa Garcia
Benet Albert Palomer
Avellana Jaime Pascual
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Menarini SA
Original Assignee
Laboratorios Menarini SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Menarini SA filed Critical Laboratorios Menarini SA
Priority to ES9902286A priority Critical patent/ES2158809B1/en
Publication of ES2158809A1 publication Critical patent/ES2158809A1/en
Application granted granted Critical
Publication of ES2158809B1 publication Critical patent/ES2158809B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nuevos derivados sulfonados como inhibidores de la ciclooxigenasa II. La presente invención se refiere a compuestos de fórmula general I, **FORMULA** inhibidores selectivos de la ciclooxigenasa-II en los que D es un grupo -C(R{sup,2}) (R{sup,3}) -C(R{sup,4}) (R{sup,5})-, -C(R{sup,2})=C(R{sup,4})- ó -C=C-; A es un birradical -CO-, -O-, -S-, ó -NH- y E es halógeno, (C{sub,1}-C{sub,6})-alquilo, (C{sub,2}-C{sub,6})-alquenilo, (C{sub,2}-C{sub,6})-alquinilo, etc, a sus sales y solvatos farmacéuticamente aceptables, y a las composiciones farmacéuticas que las contienen. Los compuestos de la presente invención son útiles en el tratamiento de la inflamación, dolor y fiebre, así como de aquellas otras afecciones que recientemente se han asociado con las ciclooxigenasas, especialmente con la ciclooxigenasa-II, como, por ejemplo, el cáncer colorectal y la enfermedad de Alzheimer. De igual modo, la presente invención se refiere a un procedimiento para la preparación de los compuestos, así como a su utilización terapéutica.New sulphonated derivatives as inhibitors of cyclooxygenase II. The present invention relates to compounds of general formula I, ** FORMULA ** selective inhibitors of cyclooxygenase-II in which D is a group -C (R {sup, 2}) (R {sup, 3}) - C (R {sup, 4}) (R {sup, 5}) -, -C (R {sup, 2}) = C (R {sup, 4}) - or -C = C-; A is a biradical -CO-, -O-, -S-, or -NH- and E is halogen, (C {sub, 1} -C {sub, 6}) -alkyl, (C {sub, 2} -C {sub, 6}) - alkenyl, (C {sub, 2} -C {sub, 6}) - alkynyl, etc., to their pharmaceutically acceptable salts and solvates, and to the pharmaceutical compositions containing them. The compounds of the present invention are useful in the treatment of inflammation, pain and fever, as well as those other conditions that have recently been associated with cyclooxygenases, especially with cyclooxygenase-II, such as, for example, colorectal cancer and Alzheimer's disease. Similarly, the present invention relates to a process for the preparation of the compounds, as well as to their therapeutic use.

ES9902286A 1999-10-18 1999-10-18 NEW SULFONATED DERIVATIVES AS INHIBITORS OF CYCLLOXYGENASA II. Expired - Fee Related ES2158809B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9902286A ES2158809B1 (en) 1999-10-18 1999-10-18 NEW SULFONATED DERIVATIVES AS INHIBITORS OF CYCLLOXYGENASA II.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9902286A ES2158809B1 (en) 1999-10-18 1999-10-18 NEW SULFONATED DERIVATIVES AS INHIBITORS OF CYCLLOXYGENASA II.

Publications (2)

Publication Number Publication Date
ES2158809A1 ES2158809A1 (en) 2001-09-01
ES2158809B1 true ES2158809B1 (en) 2002-03-16

Family

ID=8310282

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9902286A Expired - Fee Related ES2158809B1 (en) 1999-10-18 1999-10-18 NEW SULFONATED DERIVATIVES AS INHIBITORS OF CYCLLOXYGENASA II.

Country Status (1)

Country Link
ES (1) ES2158809B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192873A (en) * 1976-11-25 1980-03-11 Ciba-Geigy Corporation Anti-inflammatory 2-sulphonyl- (or -sulphinyl)-2'-aminoacetophenones
PT86407B (en) * 1986-12-31 1990-11-20 Fujisawa Pharmaceutical Co METHOD FOR PREPARING NEW ALCANO-SULFONANILIDA DERIVATIVES, AND OF PHARMACEUTICAL COMPOSITIONS UNDERSTANDING THE SAME
JP3802581B2 (en) * 1995-03-01 2006-07-26 富山化学工業株式会社 Novel biphenyl derivatives or salts thereof and anti-inflammatory agents containing them

Also Published As

Publication number Publication date
ES2158809A1 (en) 2001-09-01

Similar Documents

Publication Publication Date Title
DE69912606D1 (en) 2- (purin-9-yl) -tetrahydro-3,4-DIOL DERIVATIVES
ECSP055609A (en) "Use of IkB-kinase inhibitors for the treatment of pain"
ES2037013T3 (en) PROCEDURE FOR PREPARING TIENO-1,4-DIAZEPINES.
CY1106784T1 (en) SUBSTITUTED phenylpropionic acid derivatives as competitors of human peroxisome proliferator-activated receptor alpha (PPAR)
TR200100410T2 (en) 2- (purin-9-yl) -tetrahydrofuran-3,4-diol derivatives.
AR026052A1 (en) PURINA DERIVATIVES
PA8442001A1 (en) DERIVATIVES OF CONDENSED BICYCLIC PIRIMIDINE
SV1999000016A (en) DERIVATIVES OF 2- (PURIN-9-IL-TETRAHIDROFURAN-3,4-DIOL REF. PG3443 / SV
ES2161290T3 (en) DERIVATIVES OF QUINAZOLINA.
ES2148229T3 (en) ATERES AND THIOETERES IN POSITION 17 OF 4-AZA-STEROIDS.
ES467828A1 (en) A PROCEDURE FOR PREPARING NEW CEFEM AND CEFAM COMPOUNDS
ES2167377T3 (en) DERIVATIVES OF PIRIDINA PHARMACOLOGICALLY ACTIVE AND PROCEDURES FOR THE PREPARATION OF THE SAME.
PA8503501A1 (en) PURINA DERIVATIVES
AR037484A1 (en) A COMPOUND DERIVED FROM AMINO-TRIAZOLOPIRIDINE, A MEDICINAL PRODUCT CONTAINING ONE OR MORE OF THE COMPOUNDS, A PROCESS FOR THE PREPARATION OF THE COMPOUND AND THE USE OF THE COMPOUND
TR200100411T2 (en) 2- (Purin-9-yl) -tetrahydrofuran-3,4-diol derivatives.
CR7743A (en) NEW OXAZOL AND TIAZOL COMPOUNDS AS INHIBITOR OF THE TRANSFORMING GROWTH FACTOR (TGF)
ES2153820T3 (en) DERIVATIVES OF BENZIMIDAZOL, PROCEDURE FOR PREPARATION AND APPLICATIONS.
AR035963A1 (en) COMPOUNDS DERIVED FROM TRIFLUORMETHYLBENENE USEFUL AS INTERMEDIATES OF THE INHIBITORS OF THE PROTEIN OF TRANSFER OF THE ESTER OF CHOLESTERILE AND PROCEDURES FOR THEIR PREPARATION
AR003427A1 (en) PEPTIDES RELATED TO DOLASTATIN, PROCEDURE FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE USE OF THE SAME FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITIONS.
MX9303145A (en) 7- (2-AMINOETIL) BENZOTIAZOLONAS.
ES2009723A4 (en) DERIVATIVES OF BILIAR ACIDS, PROCEDURES FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AR021843A1 (en) DERIVATIVES OF PROPANOLAMINE SUBSTITUTED WITH HETEROCICLES, PROCEDURE FOR THEIR PREPARATION, AND ITS USE.
ES2041705T3 (en) PROCEDURE FOR THE PREPARATION OF 1- (4-HYDROXY-3,5-DI-TERC-BUTYL-BENZOIL) -HOMOPIPERAZINE AND ITS DERIVATIVES.
SE8701406D0 (en) AROMATIC COMPOUNDS, THEIR PRODUCTION PROCEDURES AND THEIR USE IN HUMAN AND VETERINARY MEDICINES AND IN COSMETICS
AR018162A1 (en) SUBSTITUTED PIRROLS, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010120

Kind code of ref document: A1

Effective date: 20010120

FD1A Patent lapsed

Effective date: 20100312